Intellectual Property

  • September 24, 2025

    Course Hero Operator Must Face School's Copyright, TM Claims

    Course Hero, a study platform where users upload materials, must face copyright and trademark claims after a Connecticut federal judge found that a for-profit Connecticut university has demonstrated enough possible harm to justify standing for alleged copyright violations, and that a 2003 U.S. Supreme Court decision does not stand in the way of its Lanham Act claims.

  • September 24, 2025

    Arcturus Sues AbbVie, Capstan Alleging Trade Secret Theft

    Arcturus Therapeutics Inc. has sued AbbVie and Capstan Therapeutics in California federal court, alleging Capstan used Arcturus' proprietary lipid nanoparticle technology to develop and patent competing drug delivery systems, which AbbVie later acquired in a $2.1 billion deal.

  • September 24, 2025

    Fed. Circ. Vacates $181M Patent Verdict Against AT&T, Nokia

    The Federal Circuit on Wednesday wiped out Finesse Wireless' $181 million verdict against AT&T and Nokia, finding issues in "confusing and unclear" expert testimony that had supported the case accusing the wireless carriers of infringing a pair of radio interference patents.

  • September 24, 2025

    IP Feud Over 'Shark Tank'-Backed Comb Settles Before Trial

    The inventor of a hair-twisting system that was featured on an episode of "Shark Tank" and received an investment from celebrity businessman Mark Cuban has settled patent infringement claims with a rival a week before the two were to go to trial.

  • September 24, 2025

    Merrill Lynch Accuses Ex-Staff, Schwab, Investor Of IP Theft

    Merrill Lynch has filed a trade secrets lawsuit against a dozen former employees, Charles Schwab and Dynasty Financial Partners, alleging the defendants conspired to start a new independent financial advisory firm with Merrill's staff and confidential information.

  • September 24, 2025

    Microsoft Cleared In Software Patent Case In Utah

    A Utah federal judge has cleared Microsoft of allegations that it infringed on claims in a patent covering an application for previewing how user commands will affect a computer document, finding that the claims were invalid in light of an earlier invention.

  • September 24, 2025

    Innoscience Claims ITC Ban Over Invalidated Patent Is 'Unjust'

    Innoscience is urging the Federal Circuit to free it from a U.S. International Trade Commission import ban, saying the Efficient Power Conversion Corp. semiconductor patent it allegedly infringes isn't valid.

  • September 24, 2025

    Judge Says No Dispute Exists In Video File Licensing Case

    A Delaware federal judge has granted dismissal to DivX LLC in a case brought by a former business ally who was seeking a declaration that it didn't run afoul of a licensing agreement between the two, saying the court has no jurisdiction in the matter.

  • September 24, 2025

    ITC's IP Cases Mainly Target Computer And Telecom Products

    New data from the U.S. International Trade Commission has shown that intellectual property activity at the agency in 2024 remained relatively the same, with investigations primarily looking into computer and telecommunications products.

  • September 24, 2025

    Blank Rome Hires Bicoastal Pair Of Patent Attys

    Blank Rome LLP announced Tuesday that it has welcomed two new patent attorneys to its ranks: a Los Angeles-based firm alum and a New York-based former Leason Ellis LLP lawyer.

  • September 24, 2025

    Judge Sends Pandora IP Claims Back To Special Master

    A California federal judge has sent summary judgment motions from online radio service Pandora Media and a group of comedians back to a special master for further consideration after it was previously recommended that Pandora prevail.

  • September 24, 2025

    Labcorp, Natera Resolve DNA Sequencing IP Suits Midtrial

    Labcorp and Natera have reached a midtrial settlement over the laboratory testing giant's claims that its competitor infringed a group of DNA sequencing patents through the sale of a cancer testing product, a Delaware federal judge said.

  • September 24, 2025

    Ex-Patent Commissioner Is Latest To Move To Private Practice

    The U.S. Patent and Trademark Office's former patent commissioner, who resigned from her position in February as the president slashed the federal workforce, has joined McDermott Will & Schulte as a counsel in Washington, D.C., the firm announced.

  • September 23, 2025

    CBP Says It Didn't Coordinate With Apple In Import Ban Case

    U.S. Customs and Border Protection told a D.C. federal court Monday that contrary to claims by Masimo Corp., emails between the agency and Apple Inc. do not show the two worked together to evade an import ban on the Apple Watch in a patent dispute with Masimo.

  • September 23, 2025

    Eli Lilly Deal In Weight Loss Drugs Trademark Suit Hits Snag

    Pharmaceutical giant Eli Lilly and two Seattle-area medical clinics tried to leave a federal court "entirely in the dark" on the finer points of their newly proposed trademark suit settlement, a Seattle federal judge held in declining to approve the deal and enter a consent judgment in the case.

  • September 23, 2025

    Sandisk Gets Support In 'Settled Expectations' Challenge

    Industry groups, professors and Unified Patents are backing Sandisk Technologies Inc.'s Federal Circuit challenge to the U.S. Patent and Trademark Office's policy of denying review of patents based on the owner's "settled expectations," saying it flouts the law and undermines the patent review system.

  • September 23, 2025

    Daybreak Wins Injunction Over EverQuest Copycat

    The company behind the online game EverQuest has been granted a preliminary injunction in California federal court against individual defendants over an unauthorized emulator of the game that allegedly makes use of copyrighted content.

  • September 23, 2025

    Fed. Circ. Gives Bayer Chance To Save Xarelto Patent Claims

    The Federal Circuit revived several claims of a patent underpinning Bayer Pharma Aktiengesellschaft's blockbuster blood thinner Xarelto on Tuesday, sending the challenge brought by Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc. and a Cipla unit back to the Patent Trial and Appeal Board.

  • September 23, 2025

    Apple Gets Judge To Ax MyPort Patent Suit Under Alice

    A Delaware federal court on Tuesday tossed for now MyPort Technologies Inc.'s lawsuit claiming Apple Inc. infringed four patents with its smartphones and tablets, finding all the patents were just "conventional."

  • September 23, 2025

    How Attys Are Riding The Mass. Biotech 'Roller Coaster'

    The first half of 2025 saw the Massachusetts biotech industry post bleak numbers, including a dip in venture capital funding and merger activity, leaving attorneys looking for creative ways to help companies with fewer public and private dollars.

  • September 23, 2025

    Cantor Fitzgerald, Citibank Hit With Trading Patent Suits

    Several financial services businesses, including Citibank and Secretary of Commerce Howard Lutnick's former firm Cantor Fitzgerald, have been sued in New York and Texas federal court over their alleged infringement of a trading patent.

  • September 23, 2025

    Fed Circ. Won't Rehear Dolby's Bid To Identify PTAB Party

    The Federal Circuit on Tuesday denied Dolby Laboratories Licensing Corp.'s request for a panel rehearing or for the full circuit to hear its appeal of a Patent Trial and Appeals Board proceeding that it prevailed in but in which it claims not all interested parties were identified.

  • September 23, 2025

    Gibson Gets $1 Guitar TM Award Upped To $168K

    After a Texas federal jury awarded guitar maker Gibson just $1 in damages from a Florida-based competitor found to have infringed trademarks for its iconic guitar shapes, a federal judge increased the award to just over $168,000 in disgorgement of profits earned through infringement.

  • September 23, 2025

    Judge Slams Hogan Estate's Standing For Sex Tape Film Suit

    A Florida federal judge who dissolved an order blocking the release of a documentary that features excerpts of Hulk Hogan's sex tape faulted representatives of his estate for bringing the lawsuit before being authorized to do so, while also saying their copyright claim might fail because of fair use.

  • September 23, 2025

    Minnesota's Deepfake Crackdown Foreshadows Legal Clashes

    Minnesota's law cracking down on deepfake videos aimed at influencing elections has drawn separate court challenges to stop its enforcement, including one by X Corp., offering a glimpse into the hurdles other states and Congress may face as they address the proliferation of digital replicas created with artificial intelligence.

Expert Analysis

  • Brand Protection Takeaways From OpenAI Trademark Case

    Author Photo

    The ongoing battle between IYO and OpenAI offers critical lessons on diligent trademark enforcement and proactive risk management for startups and established players alike navigating branding in the rapidly evolving artificial intelligence sector, say attorneys at Dykema.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • IP Due Diligence Tips For AI Assets In M&A Transactions

    Author Photo

    Artificial intelligence systems' integration into business operations creates new considerations for intellectual property due diligence in mergers and acquisitions and financing transactions, and implementing a practical approach to identifying AI assets can help avoid litigation and losses, say Armin Ghiam and Senna Hahn at Hunton.

  • How To Strengthen A Case By Mastering Expert Witness Prep

    Author Photo

    A well-prepared expert witness can bolster a case's credibility with persuasive qualifications, compelling voir dire responses and concise testimony that can withstand cross-examination, says Allison Rocker at Baker McKenzie.

  • A Look At Florida's New Protected Series LLC Legislation

    Author Photo

    A new law in Florida enhances the flexibility of using limited liability companies as the entities of choice for most privately held businesses, moving Florida into a small group of states with reliable uniform protected series legislation for series LLCs, says Louis Conti at Holland & Knight.

  • Opinion

    New USPTO Leadership Must Address Low-Quality Patents

    Author Photo

    With John Squires in line to become the new director of the U.S. Patent and Trademark Office, the agency has an opportunity to refocus its mission on prioritizing quality in patent examination and taking a harsher stance against low-quality patents and patent trolls, says Jill Crosby at Engine Advocacy & Foundation.

  • Opinion

    High Court Must Overrule Outdated Patent Eligibility Doctrine

    Author Photo

    A certiorari petition should directly ask the U.S. Supreme Court to correct its 1972 patent decision in Gottschalk v. Benson, the critical point where patent eligibility law veered from the statutory text toward judicial policymaking, says Robert Greenspoon at Dunlap Bennett.

  • Series

    Playing The Violin Makes Me A Better Lawyer

    Author Photo

    Playing violin in a string quartet reminds me that flexibility, ambition, strong listening skills, thoughtful leadership and intentional collaboration are all keys to a successful legal practice, says Julie Park at MoFo.

  • DOJ Enforcement Trends To Watch In 2nd Half Of 2025

    Author Photo

    Recent investigations, settlements and a declination to prosecute suggest that controlling the flow of goods into and out of the country, and redressing what the administration sees as reverse discrimination, are likely to be at the forefront of the U.S. Department of Justice's enforcement agenda the rest of this year, say attorneys at Baker Botts.

  • The State Of AI Adoption In The Patent Field

    Author Photo

    The use of generative artificial intelligence in patent-related practices has lagged behind early predictions, which may be explained by a number of core concerns that organizations must address before seriously considering adoption, say attorney Michael Drapkin and leadership coach Michael Colacchio.

  • Purdue Case Could Transform Patent Obviousness Analyses

    Author Photo

    If accepted for review by the U.S. Supreme Court, Purdue Pharma v. Accord Healthcare — concerning whether Purdue's abuse-deterrent opioid formulation patents were invalid as obvious — could significantly shift how courts weigh secondary considerations in patent obviousness analyses, say attorneys at Lathrop.

  • 'Top Gun' And 'Together' IP Suits Spotlight Similarity Issues

    Author Photo

    The outcome of recent lawsuits revolving around the films "Top Gun: Maverick" and "Together" may set meaningful precedents for how courts analyze substantial similarity in creative works, say attorneys at Greenspoon Marder.

  • Series

    Law School's Missed Lessons: Practicing Self-Care

    Author Photo

    Law schools don’t teach the mental, physical and emotional health maintenance tools necessary to deal with the profession's many demands, but practicing self-care is an important key to success that can help to improve focus, manage stress and reduce burnout, says Rachel Leonard​​​​​​​ at MG+M.

  • ABA Opinion Makes It A Bit Easier To Drop A 'Hot Potato'

    Author Photo

    The American Bar Association's recent ethics opinion clarifies when attorneys may terminate clients without good cause, though courts may still disqualify a lawyer who drops a client like a hot potato, so sending a closeout letter is always a best practice, say attorneys at Thompson Hine.

  • IRhythm IPR Denial Raises Key PTAB Discretion Questions

    Author Photo

    By giving the passage of time a dispositive role in denying institution of five inter partes review petitions filed by iRhythm Technologies, the U.S. Patent and Trademark Office has upended the strategic considerations for filing and defending against IPRs, disclosing prior art during prosecution, and engaging in licensing negotiations, say attorneys at Dentons.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.